Aspectos farmacológicos do Dantrolene Sódico
DOI:
https://doi.org/10.34024/rnc.2005.v13.8819Palavras-chave:
suplementoResumo
.
Downloads
Métricas
Referências
Leitão FBP, Cançado TOB. Hipertermia malígna. Rev Bras Anestesiol 1996; 46(4): 302-312.
Fruen BR, Mickelson JR, Louis CF. Dantrolene inhibition of sarcoplasmic reticulum Ca 2+release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chemistry 1997; 271:26965-26971.
Lopez JR, Allen PD, Alamo L, et al. Myoplasmic free (Ca2+) during a malignant hyperthermia apisode swine. Muscle Nerve 1988; 11(1): 82-88.
Perez C, Linares N, Cordovez G, et al. Câmbios em la (Ca2+) inducida por el dantrolene em fibras musculares de sujetos susceptibles a hipertermia maligna. Rev Colomb Anestesiol 1993; 21: 375-378.
Amaral JLG, Carvalho RB. Hipertermia maligna em: Manica J – Anestesiologia, princípios e técnicas, 3ª Ed, Porto Alegre: Artes Médicas 2004; 1207-1224.
Morgan KB, Bryant SH. The mecanism of action of dantrolene sodium. J Pharmacol Exp Ther 1977; 201(1): 138-202.
Lesh RE, Linch III C. Intracellular Ca2+regulation. In: Yaksh TL, et al (eds.) Anesthesia Biologic Foundations. Philadelphia: Lippincott-Raven Publishers, 1997, 105-30.
Hogan K. Perspectivas para o diagnóstico pré-sintomático não invasivo da susceptibilidade à hipertermia malígna com técnicas de genética molecular. Clin Anestesiol Am N 1994; 3: 569-95.
Ellis KO, Castellion AW, Honkomp LJ, et al. Dantrolene, a direct acting skeletal muscle relaxant. J Pharm Sci 1973; 62(6): 948-951.
Butterfield JL, Ellis KO. Effects of dantrolene sodium, a skeletal muscle relaxant, on the contractility of cardiac and smooth muscle. Fed Proc 1973; 72: 772.
Ellis RH, Simpson P, Tatham P, et al. The cardiovascular effects of dantrolene sodium in dogs. Anaesthesia 1975; 30(3): 318-322.
Roewer N, Dziadzka A, Greim CA, et al. Cardiovascular and metabolic responses to anestheticinduced malignant hyperthermia in swine. Anesthesiol 1995; 83: 141-159.
Flewellen EH, Nelson TE, Jones WT, et al. Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiol 1983; 59: 275-280.
Saltzman LS, Kates RA, Corke BC, et al. Hiperkalemia and cardiovascular collapse after verapamil and dantrolene administraation in swine. Anesthesia Analgesia 1984; 63(5): 473-478.
Ally AL, Horrobin DF, Manku MS, et al. Dantrolene blocks intracelular calcium release in smooth muscle: competitive antagonism of thromboxane A2. Can J Physiol Pharmacol 1978; 56(3): 520-523.
Bailey LE, Shibata S, Seriguchi DG, et al. Inhibition of the positive inotropic effect of anthopleurin - A by dantrolene. Life Sciences 1980; 26(13): 1061-1068.
Plizga A, Holl JE. Myocardial depression associated with effective refractory period prolongation after pentobarbital and procainamide but not after dantrolene. Res Comm Chem Pathol Pharmacol 1980; 28(1): 13-26.
Salata JJ, Jalife J. Effects of dantrolene sodium on the eletrophysiological properties of canine cardiac purkinje fibers. J PharmacolExp Ther 1982; 220(1): 157-166.
Britt BA. Dantrolene – Review Article. Can Anaest Soc J 1984; 31(1): 61-75.
Bowman WC, Houston J, Khan HH, et al. Effects of dantrolene sodium on respiratory and other muscles and respiratory parameters in the anaesthetised cat. Eur J Pharmacol 1979; 55(3): 293-303.
Farquhar R, Leslie GC, Part NJ. How is ventilation maintained in the presence of the muscle relaxant dantrolene sodium? A study in the anaesthetised rat. Bri J Pharmacol 1986; 88(1)79-86.
Janjic D, Wollheim CB, Sharp GWG. Selective inibition of glucose stimulated insulin release by dantrolene. Am J Phisiol, 1982; 243(1): 59-6723. Sharp GWG, Wiedenkeller DE, Pian-Smith M. Unexpected potentiation of glucose-stimulated insulin release by calcium store blockers. Diabetologia 1984; 27: 331A-332A.
Francis KT, Hanrick ME. Dantrolene inhibition of the hepátic mixed function oxidase system. Res Comm Chem Pathol Pharmacol 1979; 23(1): 69-80.
Shime J, Gare D, Andrews J, et al. Dantrolene in pregnancy: Lack of adverse effects on the fetus and newborn infant. Am J Obstet Anesth 1995; 4: 197-200.
USP DI – Dantrolen systemic in: Drug information for the health care professional, 16th edition,1996; 1151-54.
Weingarten AE, Korsh JL, Neumann GG, et al. Pospartum atony after intravenous dantrolene. Anesth Analg 1987; 66: 269-270.
Wedwl DJ, Quinlan JG, Laizzo PA. Clinical effects of intravenous dantrolene. Mayo Clin Proc 1995; 70: 241-246.
Wuis EW, Gut ACML, Vree TB, et al. Simultaneous determination of dantrolene and its metabolites, 5-hydroxydantrolene and nitro-reduced acetylated dantrolene (F-490) in plasma e urine of man and dogsby high-performance liquid chromatography. J Chrom 1982; 231(2): 401-409.
Ward A, Chaffman MO, Sorkin EM. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neroleptic malignant syndrome and update of its use in muscle spasticity. Drugs 1986; 32: 130-168.
Dykes MHM. Evaluation of muscle relaxant: dantrolene sodium. JAMA 1975; 231(8): 862-864.
Monster AW, Herman R, Meeks S, et al. Cooperative study for assessing the effects of a pharmacological agent on spasticity. Ame J Phys Med Reabil, 1973; 52(4): 163-187.
Monster AW, Tamai Y, McHenry J, et al. Dantrolene sodium: its effects on extrafusal muscle fibers. Arch Phys Med Reabil 1974; 55(8): 355-362.
Vallner JJ, Honigberg IL, Stewart JT et al. Dantrolene and metabolite levels in six patients on chronic therapy. Curr Ther Res 1979; 25(1): 79-91
Katogi Y, Tamaki N, Adachi M. Simultaneous determination of dantrolene and its metabolite, 5-hydroxy-dantrolene, in human plasma by high performance liquid chromatography. J Chrom 1982;228: 404-408.
Flewellen EH, Nelson TE. Intravenous dantrolene pharmacokinetics in malignant hyperthermia suspect patients. Anesthesiol 1985; 63(sup3A): 300.
Meyler WJ, Mols-Thurkow HW, Wesseling, H. Relationship between plasma concetration and effect of dantrolene sodium in man. Eur J Clin Pharmacol 1979; 16(3): 203-209.
Wuis EW, Hendriks HJ, Vree TB, et al. Pharmacokinetics of dantrolene in man after oral administration. World Conference on Clinical Pharmacology and Therapeutics 1983; 5: 12.
Meyler WJ, Bakker H, Kok JJ, et al. The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration. J Neurol Neurosur Psych 1981; 44:334-39.40. Vallner JJ, Sternson LA, Parsons DL. Interaction of dantrolene sodium with human serum albumin. J Pharm Sci 1976; 675: 873-877.
Morison DH. Placental transfer of dantrolene. Correspondence. Anesthesiol 1983; 59(3): 265.
Fricker RM, Hoerauf KH, Drewe J et al. Secretion of dantrolene into breast milk after acute therapy of a suspected malignant hyperthermia crisis during cesarean section. Anesthesiol 1998; 89(4):1023-25.
Herman R, Mayer N, Mecomber SA. Clinical pharmaco-physiology of dantrolene sodium. Am J Phys Med 1972; 51(6): 296-311.
Flewellen EH, Nelson TE, Bee DE. Porcine malignant hyperthermia – failure of dantrolene dose response to diagnose susceptibility (halotane effect). Can Anaesth Soc J 1980b; 27(1): 16-21.
Free CW, Jaimon MPC. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report. N Zeal Med J 1978; 88: 493-494.
Pandit SK, Khotary SP, Cohen P. Orally administered dantrolene for prophylaxis of malignant hyperthermia. Anesthesiol 1979; 50(2): 156-158.
Sengupta C, Meyer VA, Carafoli E. Binding of dantrolene sodium to muscle intracellular membranes. FEBES Letters 1980; 117(1): 37-38.
Ellis KO, Wessells FL. Muscle relaxant properties of the identified metabolites of dantrolene. Naunyn-Schmiedeberg’s. Arch Pharmacol 1978; 301(3): 237-240.
Lietman PS, Haslan RHA, Walcher JR. Pharmacology of dantrolene sodium in children. Arch Phys Med Rehabil 1974; 55: 388-392.
Meyler WJ, Vermeer GA, Agoston S et al. Excretion patern of dantrolene sodium and metabolites in patients with and without cholecystectomy. Proceedings of the World Conference on Clinical Pharmacology and Therapeutics, London, 1980; Abstract 0796.
Downloads
Publicado
Como Citar
Edição
Seção
Publicado: 2005-09-30
Português
English
Español
